LifeSignals

Overview
News
Next-gen Medical Devices?
Product stageSegments
Go-to-Market
?
Monitoring devices
?

LifeSignals specializes in wireless healthcare monitoring technology through its advanced wearable biosensors. The company's flagship product, the UbiqVue 2A multi-parameter system, received FDA 510(k) clearance for continuous wireless remote patient monitoring. The chest-worn biosensor monitors multiple physiological parameters including SpO₂ levels, pulse rate, respiration rate, photoplethysmography (PPG), and body temperature. The data is encrypted and transmitted in near real-time to a secure cloud-based system, allowing healthcare professionals to access information and receive alerts through a web portal.

The company's product portfolio includes the LX1550 Multiparameter Remote Monitoring Platform, which measures five vital signs including skin temperature and respiration rate for up to five days. LifeSignals also offers the FDA-cleared Wearable Biosensor with 4-in-1 capabilities including MCT, Holter, Extended Holter, and Wireless Event monitoring, which can record ECG continuously for up to 30 days.

In March 2020, LifeSignals merged with Ireland-based connected health provider Renew Health to form LifeSignals Group. The company utilizes white light spectral SpO₂ patented technology licensed from BioIntelliSense and has developed its product-level design and processing technology in partnership with them.

Key customers and partnerships

LifeSignals has established partnerships with healthcare providers across multiple countries. In March 2023, the company partnered with Amala Hospital in Kerala, India, to implement its iMS technology across cardiology and medicine departments. The company has also successfully implemented its monitoring systems in hospitals for Covid-19 patients in India and has expanded its presence to Europe, UK, Singapore, and the Philippines.

In January 2023, UltraLinQ healthcare Solutions partnered with LifeSignals to launch an end-to-end Wireless Holter Monitoring ECG Analysis and Reporting System. The company works with OEMs, service providers, IDTFs, and distributors globally to deploy its healthcare monitoring solutions.


Sources

Disclaimer: This company profile has been generated using data obtained through automated web searches and advanced generative AI technology. While we strive to ensure the accuracy and reliability of our sources, auto-generated information could be outdated or inaccurate and should be verified independently.
HQ location:
39355 California Street Suite 303 Fremont CA USA
Founded year:
2006
Employees:
11-50
IPO status:
Private
Total funding:
USD 15.7 mn
Last Funding:
USD 10.2 mn (Series C; Sep 2016)
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.